Arcturus Therapeutics Holdings (ARCT) Total Liabilities (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Total Liabilities data on file, last reported at $54.0 million in Q1 2026.

• Quarterly Total Liabilities fell 44.86% year-over-year to $54.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.0 million (down 44.86% YoY) and the FY2025 annual result came in at $57.2 million, down 44.55% from the prior year.
• Total Liabilities eased to $54.0 million in Q1 2026, from $57.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $180.1 million in Q4 2022 to a low of $54.0 million in Q1 2026.
• A 5-year average of $124.1 million and a median of $141.6 million in 2023 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities rose 22.02% — and 2025, when it tumbled 46.88%.
• Tracing ARCT's Total Liabilities over 5 years: stood at $180.1 million in 2022, then fell by 16.21% to $150.9 million in 2023, then slumped by 31.68% to $103.1 million in 2024, then slumped by 44.55% to $57.2 million in 2025, then retreated by 5.45% to $54.0 million in 2026.
• The last three Total Liabilities figures came in at $54.0 million (Q1 2026), $57.2 million (Q4 2025), and $57.8 million (Q3 2025), per Business Quant data.